Perinatal exposure to 5-metoxytryptamine, behavioural-stress reactivity and functional response of 5-HT1A receptors in the adolescent rat

Behavioural Brain Research

Volumn 186, Issue 1, 2008, Pages 98-106

  Cannizzaro, C ^a   Plescia, F ^a   Gagliano, M ^a   Cannizzaro, G ^a   Mantia, G ^a   La Barbera, M ^a   Provenzano, G ^a   Cannizzaro, E ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

5 HT1A receptors; Acute LY 228729 and WAY 100635; Adolescent rat; Behavioural stress reactivity; Perinatal 5MT

Indexed keywords

4 DIPROPYLAMINO 1,3,4,5 TETRAHYDROBENZ[CD]INDOLE 6 CARBOXAMIDE; 5 METHOXYTRYPTAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PRESYNAPTIC RECEPTOR; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR;

ADAPTATION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; EXPOSURE; FEMALE; FORCED SWIMMING TEST; GESTATION PERIOD; IMMOBILIZATION; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; PERINATAL PERIOD; PRIORITY JOURNAL; PROGENY; RAT; STRESS;

5-METHOXYTRYPTAMINE; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANXIETY; BRAIN; DRUG SYNERGISM; ERGOLINES; EXPLORATORY BEHAVIOR; FEMALE; MALE; MOTOR ACTIVITY; PIPERAZINES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PRESYNAPTIC TERMINALS; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGENTS; SEX FACTORS; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL; SYNAPSES;

EID: 36049033042     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.07.036     Document Type: Article

References (70)

1. Aghajanian G.K., and Sanders-Bush E. Serotonin. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Psychopharmacology: the fifth generation of progress (2002), Raven Press, New York 15-34
2. Aitken A.R., and Tork I. Early development of serotonin-containing neurons and pathways as seen in whole-mount preparations of the fetal rat brain. J Comp Neurol 274 (1988) 32-47
3. Albert P.R., Lembo P., Storring J.M., Charest A., and Saucier C. The 5-HT1A receptor: signaling, desensitization, and gene transcription. Neuropsychopharmacology 14 (1996) 19-25
4. Amaral D.G., and Corbett B.A. The amygdala, autism and anxiety. Novartis foundation symposium, vol 251 (2003) 177-197
5. Archer J. Tests for emotionality in rats and mice: a review. Anim Behav 21 (1973) 205-235
6. Aulich D. Escape versus exploratory activity: an interpretation of rats' behaviour in the open field and a light-dark preference test. Behav Proc 1 (1976) 153-164
7. Baldwin D., and Rudge S. The role of serotonin in depression and anxiety. Int J Clin Psychopharmacol 9 (1995) 41-45
8. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
9. 1A receptors. Neurosci Lett 127 (1991) 173-176
10. Benvenga M.J., and Leander J.D. Antidepressant-like effect of LY 228729 as measured in the rodent forced swim paradigm. Eur J Pharmacol 239 (1993) 249-252
11. Bohus B., Benus R.F., Fokkema D.S., Koolhaas J.M., Nyakas C., van Dortmerssen G.A., et al. Neuroendocrine states and behavioural and physiological stress responses. Prog Brain Res 72 (1987) 57-70
12. Cannizzaro C., Martire M., Cannizzaro E., Provenzano G., Gagliano M., Carollo A., et al. Long-lasting handling affects behavioural reactivity in adult rats of both sexes prenatally exposed to diazepam. Brain Res 904 (2001) 225-233
13. Cannizzaro C., Martire M., Cannizzaro E., Monastero R., Gagliano M., Mineo A., et al. Effects of 8-OH-DPAT on open field performance of young and aged rats prenatally exposed to diazepam: a tool to reveal 5-HT1A receptor function. Eur Neuropsychopharmacol 13 (2003) 209-217
14. 1A receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioural effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model. Neuropharmacology 39 (2000) 1037-1043
15. Chapillon P., Patin V., Roy V., Vincent A., and Caston J. Effects of pre- and postnatal stimulation on developmental, emotional and cognitive aspects of rodents: a review. Dev Psychobiol 41 (2002) 373-387
16. Corradetti R., Le Poul E., Laaris N., Hamon M., and Lanfumey L. Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl) ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro. J Pharmacol Exp Ther 278 (1996) 679-688
17. 1A agonists. Synapse 14 (1993) 297-304
18. Dal-Zotto S., Martì O., and Armario A. Influence of single or repeated experience of rats with forced swimming on behavioural and physiological responses to the stressor. Behav Brain Res 114 (2000) 175-181
19. Dawson G.R., and Tricklebank M.D. Use of the elevated plus-maze in the search for novel anxiolytic agents. Trend Pharmacol Sci 16 (1995) 33-36
20. De La Garza R., and Cunningham K.A. The effects of the 5-hydroxytriptamine 1A agonist 8-hydroxy 2-(di-n-propylamino) tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioural sensitization: a microanalysis of locomotor activity. J Pharmacol Exp Ther 292 (2000) 610-617
21. Denemberg V.H. Open field behaviour in the rat: what does it mean. Ann NY Acad Sci 159 (1969) 852-859
22. Detke M.J., Wieland J., and Lucki I. Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5-HT receptor antagonists. Psychopharmacology 119 (1995) 47-54
23. Detke M.J., Rickels M., and Lucki I. Active behaviours in the forced swimming test differently produced by serotonergic and noradrenergic antidepressants. Psychopharmacolgy 121 (1995) 66-72
24. De Vry J. 5-HT1A receptor ligands: recent developments and controversial issues. Psychopharmacology 121 (1995) 1-26
25. 1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur Neuropsychopharmacol 14 (2004) 487-495
26. Flaugh M.E., Muller D.L., Fuller R.W., and Mason N.R. 6-Substituted 1,3,4,5-tetrahydrobenz[cd]indol-4-amines: potent serotonin agonists. J Med Chem 31 (1988) 1746-1753
27. Foreman M.M., Fuller R.J., Leander D.J., Benvenga M.J., Wong D.T., Nelson D.L., et al. Preclinical studies on LY 228729: a potent and selective serotonin (1A) agonist. J Pharmacol Exp Ther 267 (1993) 58-71
28. Forster E.A., Cliffed I.A., Bill D.J., Dover G.M., Jones D., Reilly Y., et al. A pharmacological profile of the selective silent 5-HT(1A) receptor antagonist WAY-100635. Eur J Pharmacol 281 (1995) 81-88
29. Glaser T., and Devry J. Neurobiology of 5-HT 1A receptors. In: Stahl S.M., Gaspar M., and Hesselink J.M. (Eds). Serotonine 1A receptors in depression and anxiety (1992), Raven Press, New York 35-53
30. Graeff F.G., Guimaraes F.S., Andrade G.C.S., and Deakin J.F.W. Role of 5-HT in stress, anxiety and depression. Pharmacol Biochem Behav 54 (1996) 129-141
31. Hamon M. The main feature of central 5-HT1A receptors. In: Baumgarten M., and Gothert M. (Eds). Serotoninergic neurons and 5-HT receptors in the CNS. Handbook of experimental pharmacology (1997), Springer, Berlin 239-268
32. Handley S.L. 5-hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther 66 (1995) 103-148
33. Heal D.J., Luscombe G.P., and Martin K.F. Pharmacological identification of 5HT receptor subtypes using behavioural models. In: Marsden C.D., and Heal D.J. (Eds). Central serotonin receptors and psychotropic drugs (1992), Blackwell Scientific Publication, London 56-99
34. Heisler L.K., Chu H.-M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., et al. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Nat Acad Sci 95 (1998) 15049-15054
35. Hillegaart V., Wadenberg M.L., and Ahlenius S. Effects of 8-OH-DPAT on motor activity in the rat. Pharmacol Biochem Behav 32 (1989) 797-800
36. Hjorth S., and Magnusson T. The 5-HT(1A) receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 338 (1988) 463-471
37. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54 (1996) 21-30
38. Kahne D., Tudorica A., Borella A., Shapiro L., Johnstone F., Huang W., et al. Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiol Behav 75 (2002) 403-410
39. Kelly A.E. Locomotor activity and exploration. In: Sahgal (Ed). Behavioural neuroscience. A practical approach vol. 2A (1993), Oxford Press, Oxford 1-21
40. Korte M.S., De Kloet E.R., Buwalda B., Stephan D., Bouman S.D., and Bohus B. Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test. Eur J Pharmacol 301 (1996) 19-25
41. Lauder J.M., and Krebs H. Serotonin as differentiation signal in early neurogenesis. Dev Neurosci 11 (1978) 15-30
42. Lauder J.M. Ontogeny of serotonergic system in the rat: serotonin as a developmental signal. Ann NY Acad Sci 600 (1990) 297-314
43. Lauder J.M., Liu J., and Grayson D.R. In utero exposure to serotonergic drugs alters neonatal expression of 5-HT(1A) receptor transcripts: a quantitative RT-PCR study. Int J Dev Neurosci 18 (2000) 171-176
44. Lidov H.G., and Molliver M.E. Immunohistochemical study of the developmental of serotonergic neurons in the rat CNS. Brain Res Bull 9 (1982) 559-604
45. Liebsch G., Montkowski A., Holsboer F., and Landgraf R. Behavioral profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour. Behav Brain Res 94 (1998) 301-310
46. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44 (1998) 151-162
47. 1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology 125 (1996) 89-91
48. Mazer C., Muneyyirci J., Tahery K., Raio N., Borella A., and Whitaker-Azmitia P.M. Serotonin depletion during synaptogenesis lead to decreased synaptic density and learning deficit in the adult rat. A model of neurodevelopmental disorders with cognitive deficits. Brain Res Dev 760 (1997) 68-64
49. 1A agonists. Mol Pharmacol 37 (1990) 231-237
50. Patel T.D., and Zhou F.C. Ontogeny of 5-HT1A receptor expression in the developing hippocampus. Dev Brain Res 157 (2005) 42-57
51. Pellow S., Chopin P., File J.E., and Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
52. Pellow S., and File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24 (1986) 525-529
53. Rènerìc J.P., and Lucki. Antidepressant behavioural effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychpharmacology 136 (1998) 190-197
54. Rodgers R.J., and Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Behav Rev 21 (1997) 801-810
55. 2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats. Eur Neuropsychopharmacol 9 (1999) 287-294
56. Shemer A.V., Azmitia E.C., and Whitaker-Azmitia P.M. Dose-related effects of prenatal 5-methoxytryptamine (5MT) on development of serotonin terminal density and behaviour. Dev Brain Res 59 (1991) 59-63
57. Spear L.P. The adolescent brain and age-related behavioural manifestations. Neurosci Behav Rev 24 (2000) 417-463
58. Suwabe A., Kubota M., Niwa M., Kobayashi K., and Kanba S. Effect of a 5-HT1A receptor agonist, flesinoxan, on the extracellular noradrenaline level in the hippocampus and on the locomotor activity of rats. Brain Res 858 (2000) 393-401
59. Vallée M., Mayo W., Dellu F., Moal M.L., Simon H., and Maccari S. Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion. J Neurosci 17 (1997) 2626-2636
60. Van de Kar L.D., Richardson-Morton K.D., and Rittenhouse P.A. Stress: neuroendocrine and pharmacological mechanisms. Methods Archiv Exp Pathol 14 (1991) 133-173
61. Welker W.I. Free versus forced exploration of a novel situation by rats. Psychol Rep 3 (1957) 95-98
62. Whitaker-Azmitia P.M., and Azmitia E.C. Auto-regulation of fetal serotonergic neuronal development: role of high affinity serotonin receptors. Neurosci Lett 67 (1986) 307-331
63. Whitaker-Azmitia P.M., Lauder J.M., Shemer A., and Azmitia E.C. Postnatal changes in serotonin receptors following prenatal alterations in serotonin levels: further evidence for functional fetal serotonin receptors. Dev Brain Res 33 (1987) 285-289
64. Whitaker-Azmitia P.M., Shemer A.V., Caruso J., Molino L., and Azmitia E.C. Role of high affinity serotonin receptors in neuronal growth. Ann NY Acad Sci 600 (1990) 315-333
65. Whitaker-Azmitia P.M., Druse M., Walker P., and Lauder J.M. Serotonin as a developmental signal. Behav Brain Res 73 (1995) 19-29
66. Whitaker-Azmitia P.M. Serotonin and brain development: role in human developmental disease. Brain Res Bull 56 (2001) 479-485
67. Whitaker-Azmitia P.M. Behavioural and cellular consequences of increasing serotonergic activity during brain development: a role in autism?. Int J Dev Neurosci 23 (2005) 75-83
68. Yan W., Wilson C.C., and Haring J.H. 5-HT(1a) receptor mediates the neurotrophic effect of serotonin on developing dentate granule cells. Dev Brain Res 98 (1997) 185-190
69. Yan W., Wilson C.C., and Haring J.H. Effects of neonatal serotonin depletion on the development of rat dentate granule cells. Dev Brain Res 98 (1997) 177-184
70. Yocca F.D., Iben L., and Meller E. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine receptors negatively coupled to adenyl cyclase activity in rat hippocampal membranes. Mol Pharmacol 41 (1992) 1065-1072